Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine

• Published in: Vaccine Vol. 32; no. 25; pp. 3019 - 3024
• Main Authors: Daley, Matthew F., Yih, W. Katherine, Glanz, Jason M., Hambidge, Simon J., Narwaney, Komal J., Yin, Ruihua, Li, Lingling, Nelson, Jennifer C., Nordin, James D., Klein, Nicola P., Jacobsen, Steven J., Weintraub, Eric
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Ltd 23.05.2014; Elsevier; Elsevier Limited
• Subjects: Acellular pertussis; Adverse Drug Reaction Reporting Systems; Age; Allergy and Immunology; Anaphylaxis; Applied microbiology; Bacterial diseases; Biological and medical sciences; Child; Child, Preschool; children; Codes; Diphtheria; Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage; Diphtheria-Tetanus-Pertussis Vaccine - adverse effects; Disease control; Electronic Health Records; Encephalitis; Ent and stomatologic bacterial diseases; Enterovirus C; Fundamental and applied biological sciences. Psychology; Human bacterial diseases; Human subjects; Humans; Immunization; Inactivated poliovirus combined vaccine; Infectious diseases; Licenses; Medical sciences; Meningitis; Microbiology; Miscellaneous; monitoring; Poliovirus Vaccine, Inactivated - administration & dosage; Poliovirus Vaccine, Inactivated - adverse effects; Population; Product Surveillance, Postmarketing; Prospective Studies; Public health; risk; Risk assessment; Safety; seizures; Stroke; Surveillance; Tetanus; United States; vaccination; Vaccine; Vaccine safety; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Combined - administration & dosage; Vaccines, Combined - adverse effects; Virology; Whooping cough; United States; United States > US; MMRV; Immunization; DTaP–IPV; VSD; Vaccine safety; Vaccine; Diphtheria; IPV; MMR; Surveillance; ICD-9-CM; Inactivated poliovirus combined vaccine; ACIP; Tetanus; MCOs; Acellular pertussis; DTaP; ED; International Classification of Diseases, 9th Revision, Clinical Modification; measles–mumps–rubella–varicella vaccine; diphtheria, tetanus, and acellular pertussis vaccine; inactivated poliovirus vaccine; medical care organizations; Advisory Committee on Immunization Practices; diphtheria, tetanus, acellular pertussis and inactivated poliovirus combined vaccine; emergency department; Vaccine Safety Datalink; measles–mumps–rubella vaccine; Picornaviridae; Enterovirus; Mixed vaccine; Poliovirus; Infection; Virus; Bacteriosis; Inactivated strain
• ISSN: 0264-410X; 1873-2518; 1873-2518
• DOI: 10.1016/j.vaccine.2014.03.063

•DTaP–IPV vaccine safety was monitored through weekly surveillance activities.•Eight potentially serious adverse event groups were assessed.•More than 200,000 vaccine doses were given during the 3.5 year surveillance period.•None of the adverse events monitored was associated with DTaP–IPV vaccinati...